Results 171 to 180 of about 299,819 (305)

Cytokine Engineering Approaches for Regenerative Medicine

Advanced Therapeutics, EarlyView.
Engineered cytokines represent a powerful strategy to promote tissue repair and regeneration by precisely modulating immune responses. This review highlights recent advances in cytokine engineering, including strategies to enhance half‐life, improve tissue and cell targeting, and control receptor signaling.
Shiyi Li, Wenhao You, Mikaël M. Martino
wiley   +1 more source

Role of Adenovirus Antigens in the Induction of Virus Neutralizing Antibody

, 1968
Lena Kjellén, H. G. Pereira
openalex   +1 more source

The Hemagglutination Inhibition Test for Rubella: A Comparison of Its Sensitivity to That of Neutralization, Complement Fixation and Fluorescent Antibody Tests for Diagnosis of Infection and Determination of Immunity Status [PDF]

, 1967
Edwin H. Lennette, Nathalie J. Schmidt, Robert L. Magoffin   +2 more
openalex   +1 more source

Rewiring Neuroimmunity: Nanoplatform Innovations for CNS Disease Therapy

Advanced Therapeutics, EarlyView.
This review explores emerging nanoplatform strategies designed to modulate neuroimmune responses for treating central nervous system (CNS) disorders. It examines structural and microenvironmental barriers, advances in multifunctional and targeted nanotechnologies, and highlights clinical progress and translational challenges, offering insights into the
Muhammad Usman Akbar, Weiwei Guo, Xin Shen, Yimeng Fang, Yilin Liu, Peng‐Yuan Wang, Roey Elnathan, Yaping Chen   +7 more
wiley   +1 more source

Optimizing the breadth of SARS-CoV-2-neutralizing antibodies in vivo and in silico. [PDF]

Hum Vaccin Immunother
Kuroda D, Moriyama S, Sasaki H, Takahashi Y.   +3 more
europepmc   +1 more source

Neutralization of Different Murine Interferons by Antibody [PDF]

, 1967
M Boxaca, Kurt Paucker
openalex   +1 more source

Exploring AAV‐Mediated Gene Therapy for Inner Ear Diseases: from Preclinical Success to Clinical Potential

Advanced Science, EarlyView.
Current preclinical studies of AAV‐mediated gene therapy explore different strategies based on the characteristics of inner ear diseases. For genetic hearing loss, approaches include the replacement of a “good gene,” removal of a “bad gene,” or direct correction of mutations through base editing.
Fan Wu, Wuhui He, Yun Xiao, Qiong Wu, Qing Zhang, Tiesong Zhang, Lei Xu, Xinyi Pang   +7 more
wiley   +1 more source

Vaccination-induced neutralizing antibodies in immunocompetent hosts correlate with protection against rickettsiae. [PDF]

NPJ Vaccines
Velatooru LR, Plante J, Chu CY, Cutchin G, Zhu B, Burkhardt N, Roach C, Cong Y, Karim S, Kuo YF, Walker DH, Munderloh U, Fang R.   +12 more
europepmc   +1 more source

PROS1‐MERTK Axis Drives Tumor Microenvironment Crosstalk and Progression in Papillary Thyroid Microcarcinoma

Advanced Science, EarlyView.
Identifying biomarkers associated with PTC, particularly those related to PTMC progression, is crucial for precise risk stratification and treatment planning. This study utilized single‐cell RNA sequencing on 19 surgical tissue specimens, confirmed PROS1/MERTK axis as a critical component of the cellular microenvironment and a key regulatory mechanism ...
Wenqian Zhang, Ye Zhang, Zhu Liu, Zhiyuan Wang, Huaqin Wang, Xiaoyu Ji, Hongyue Su, Fan Yang, Lirong Yan, Ying Xu, Hao Zhang, Wei Sun   +11 more
wiley   +1 more source

Potent Cross-neutralizing Antibodies Reveal Vulnerabilities of Henipavirus Fusion Glycoprotein. [PDF]

Adv Sci (Weinh)
Ren Y, Fan P, Zhang X, Fang T, Chen Z, Yao Y, Chi X, Zhang G, Zhao X, Sun B, Li F, Liu Z, Song Z, Zhang B, Peng C, Li E, Yang Y, Li J, Chiu S, Yu C.   +19 more
europepmc   +1 more source